Mylan settles suit over asthma, allergy drug

PITTSBURGH — Mylan has settled a patent infringement suit over a drug used to treat respiratory diseases, Mylan said.
The generic drug maker said it resolved a patent litigation suit filed by Shionogi and Cima Labs over prednisolone sodium phosphate orally disintegrating tablets, a generic version of Orapred ODT. Mylan is hoping to market its generic version of the drug in the 10-mg, 15-mg and 30-mg strengths. The drug is used to treat asthma and certain allergic conditions.....

Source: drugstorenews.com



Seasonal allergies can trigger asthma

ROCKFORD (WREX) - As we head into the fall, allergies are in full swing.  If you suffer from allergies, there is a second problem you need to be aware of: asthma.....

Read more here: wrex.com